These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cloning and characterization of human tumor cell interstitial collagenase. Templeton NS, Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG. Cancer Res; 1990 Sep 01; 50(17):5431-7. PubMed ID: 2167156 [Abstract] [Full Text] [Related]
4. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Moll UM, Youngleib GL, Rosinski KB, Quigley JP. Cancer Res; 1990 Oct 01; 50(19):6162-70. PubMed ID: 2169335 [Abstract] [Full Text] [Related]
5. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG. Cancer Res; 1991 Jan 01; 51(1):439-44. PubMed ID: 1846313 [Abstract] [Full Text] [Related]
6. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Templeton NS, Stetler-Stevenson WG. Cancer Res; 1991 Nov 15; 51(22):6190-3. PubMed ID: 1657382 [Abstract] [Full Text] [Related]
8. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. Turpeenniemi-Hujanen T, Thorgeirsson UP, Hart IR, Grant SS, Liotta LA. J Natl Cancer Inst; 1985 Jul 15; 75(1):99-103. PubMed ID: 2989606 [Abstract] [Full Text] [Related]
9. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB. Oncogene; 2001 Oct 25; 20(48):7051-63. PubMed ID: 11704829 [Abstract] [Full Text] [Related]
10. Mechanism of control of trophoblast invasion in situ. Graham CH, Lala PK. J Cell Physiol; 1991 Aug 25; 148(2):228-34. PubMed ID: 1652588 [Abstract] [Full Text] [Related]
11. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M. Oncogene; 1992 Jan 25; 7(1):77-83. PubMed ID: 1311064 [Abstract] [Full Text] [Related]
14. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT, Sugiura Y, Laug WE, Sun B, Garcia A, DeClerck YA. J Cell Physiol; 1996 May 25; 167(2):333-40. PubMed ID: 8613475 [Abstract] [Full Text] [Related]
18. A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes. Davis GE, Martin BM. Cancer Res; 1990 Feb 15; 50(4):1113-20. PubMed ID: 2297760 [Abstract] [Full Text] [Related]
19. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression. Mackay AR, Gomez DE, Nason AM, Thorgeirsson UP. Lab Invest; 1994 Jun 15; 70(6):800-6. PubMed ID: 8015284 [Abstract] [Full Text] [Related]
20. Blocking of collagenase secretion by estramustine during in vitro tumor cell invasion. Wang M, Stearns ME. Cancer Res; 1988 Nov 15; 48(22):6262-71. PubMed ID: 2846150 [Abstract] [Full Text] [Related] Page: [Next] [New Search]